bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.492
-0.003 (-0.57%)
At close: Oct 29, 2024, 4:00 PM
0.485
-0.007 (-1.36%)
After-hours: Oct 29, 2024, 6:35 PM EDT
bluebird bio Stock Forecast
BLUE's stock price has decreased by -81.95% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 9 analysts with 12-month price forecasts for bluebird bio stock have an average target of 4.63, with a low estimate of 1.02 and a high estimate of 13. The average target predicts an increase of 841.44% from the current stock price of 0.49.
Analyst Consensus: Hold
* Price targets were last updated on Sep 25, 2024.
Analyst Ratings
The average analyst rating for bluebird bio stock from 11 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 5 | 5 | 5 | 6 | 6 | 6 |
| Sell | 2 | 2 | 2 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +306.67% | Sep 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $4 → $3 | Strong Buy | Maintains | $4 → $3 | +510.00% | Aug 15, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $4 | Hold | Reiterates | $4 | +713.34% | Aug 15, 2024 |
| Barclays | Barclays | Buy Maintains $8 → $4 | Buy | Maintains | $8 → $4 | +713.34% | Aug 15, 2024 |
Financial Forecast
Revenue This Year
95.38M
from 29.50M
Increased by 223.37%
Revenue Next Year
234.26M
from 95.38M
Increased by 145.60%
EPS This Year
-1.45
from -1.93
EPS Next Year
-0.85
from -1.45
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 153.9M | 407.0M | 428.4M | ||
| Avg | 95.4M | 234.3M | 298.1M | ||
| Low | 62.7M | 118.6M | 190.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 421.8% | 326.7% | 82.9% | ||
| Avg | 223.4% | 145.6% | 27.2% | ||
| Low | 112.6% | 24.3% | -18.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.00 | -0.16 | -0.51 | ||
| Avg | -1.45 | -0.85 | -0.77 | ||
| Low | -2.24 | -1.20 | -1.00 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.